29CA Parvizi, Javad - Thomas Jefferson University - Thomas Jefferson University
jxp217

Javad Parvizi, MD, FRCS

Contact Dr. Parvizi

925 Chestnut Street
5th Floor
Philadelphia, PA 19107

(800) 321-9999

Most Recent Peer-reviewed Publications

  1. CORR Insights®: Otto Aufranc Award: A Multicenter, Randomized Study of Outpatient versus Inpatient Total Hip Arthroplasty
  2. The Mark Coventry, MD, Award: Oral Antibiotics Reduce Reinfection After Two-Stage Exchange: A Multicenter, Randomized Controlled Trial
  3. Tranexamic Acid Can Be Administered to Arthroplasty Patients Who Receive Aspirin for Venous Thromboembolic Prophylaxis
  4. The Alpha-defensin Test for Periprosthetic Joint Infections Is Not Affected by Prior Antibiotic Administration
  5. Single vs Repeat Surgical Skin Preparations for Reducing Surgical Site Infection After Total Joint Arthroplasty: A Prospective, Randomized, Double-Blinded Study
  6. Blood management after total joint arthroplasty in the United States: 19-year trend analysis
  7. In Reply
  8. Direct Cost and Complications Associated With Total Joint Arthroplasty in Patients With Preoperative Anxiety and Depression
  9. Urinary Retention is Rare After Total Joint Arthroplasty When Using Opioid-Free Regional Anesthesia
  10. Diagnosis of Periprosthetic Infection. Novel Developments
  11. Management of Hip Pain in Young Adults
  12. Diagnosis of Periprosthetic Joint Infection Following Hip and Knee Arthroplasty
  13. Patient-Controlled Fentanyl Iontophoretic Transdermal System Improved Postoperative Mobility Compared to Intravenous Patient-Controlled Analgesia Morphine: A Pooled Analysis of Randomized, Controlled Trials
  14. Identifying Patient-Specific Pathology in Osteoarthritis Development Based on MicroCT Analysis of Subchondral Trabecular Bone
  15. Aspirin Is as Effective as and Safer Than Warfarin for Patients at Higher Risk of Venous Thromboembolism Undergoing Total Joint Arthroplasty
  16. Periprosthetic joint infection in total knee arthroplasty: Current concepts
  17. Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee
  18. Human Immunodeficiency Virus and Total Joint Arthroplasty: The Risk for Infection Is Reduced
  19. Individualized Risk Model for Venous Thromboembolism After Total Joint Arthroplasty
  20. In Reply
0